ASSEMBLY BIOSCIENCES, INC. business relationships
Companies named in ASSEMBLY BIOSCIENCES, INC.’s 10-K filed 2026-03-19, and public companies whose annual reports name ASSEMBLY BIOSCIENCES, INC.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 5.4 / 10
- AI naming
- 70 / 100 Top 1% in its category
- Agent readiness
- 0 / 100
- AI adoption
- 0 / 100
Named in ASSEMBLY BIOSCIENCES, INC.’s annual report 5
“At the commencement of the arrangement, the Company concluded Gilead was a customer and accordingly, the Gilead Collaboration Agreement was within the scope of the revenue from contracts with customers guidance.” SEC filing
“Under the Gilead Collaboration Agreement, Gilead exclusively licensed to the Company its HPI program and NNPI program, while retaining opt-in rights to these programs and has an option to take an exclusive license, on a program-by-program basis, to all of the Company's other current and future pipel...” SEC filing
“For additional information regarding the Gilead Collaboration, see "Collaboration and License Agreements-Gilead Sciences, Inc."” SEC filing
“We expect our collaboration with Gilead to be a critical part of the development, manufacture and commercialization of our product candidates.” SEC filing
“The Arbutus Biopharma Agreement was within the scope of the collaborative arrangements guidance as both parties were active participants and were exposed to significant risks and rewards dependent on the success of the collaborative activity.” SEC filing
Companies whose annual reports name ASSEMBLY BIOSCIENCES, INC. 1
“Additionally, there are two known small pharmaceutical companies developing programs with various mechanisms of action, including Huahui Health and Assembly Biosciences (in partnership with Gilead).” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.